sorafenib has been researched along with Injuries, Radiation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dudek, A; Konety, SH; Masri, SC; Misselt, AJ | 1 |
Azuma, K; Esaki, M; Kitazono, T; Matsumoto, T; Nakamura, S; Ooho, A; Yanai, S | 1 |
Lee, YC; Park, YH; Roh, SY | 1 |
Peters, NA; Richel, DJ; Stalpers, LJ; Verhoeff, JJ | 1 |
4 other study(ies) available for sorafenib and Injuries, Radiation
Article | Year |
---|---|
Radiation recall reaction causing cardiotoxicity.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Chemoradiotherapy; Coronary Angiography; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiation Dosage; Radiation Injuries; Risk Factors; Sorafenib; Whole Body Imaging | 2014 |
Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Duodenitis; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Radiation Injuries; Radiotherapy; Receptor Protein-Tyrosine Kinases; Sorafenib | 2015 |
Effect of sorafenib on experimental choroidal neovascularization in the rat.
Topics: Animals; Benzenesulfonates; Choroidal Neovascularization; Computer Systems; Disease Progression; Dose-Response Relationship, Drug; Down-Regulation; Fluorescein Angiography; Gene Expression; Intercellular Adhesion Molecule-1; Lasers; Male; Niacinamide; Phenylurea Compounds; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pyridines; Radiation Injuries; Rats; Rats, Inbred BN; Sorafenib; Vascular Endothelial Growth Factor A | 2010 |
Bowel perforation after radiotherapy in a patient receiving sorafenib.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Combined Modality Therapy; Female; Humans; Intestinal Perforation; Kidney Neoplasms; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Radiation Injuries; Skin Neoplasms; Sorafenib | 2008 |